Company Profile
Pfizer Ventures is the venture capital arm of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Established to identify and invest in early-stage companies that align with Pfizer’s long-term strategy, Pfizer Ventures focuses on accelerating innovation in areas such as drug discovery, therapeutics, diagnostics, and healthcare technologies.
The firm manages a dedicated investment portfolio, supporting biotech startups that are developing groundbreaking science and technologies across oncology, immunology, neuroscience, rare diseases, and digital health. Pfizer Ventures offers more than just capital; it brings deep scientific expertise, commercial insight, and access to Pfizer’s global network of R&D and business leaders.
With an active presence in North America, Europe, and selected international markets, Pfizer Ventures seeks to foster partnerships that not only yield financial returns but also contribute to Pfizer’s overarching goal of delivering breakthroughs that change patients’ lives. The team operates with a collaborative, long-term mindset that supports companies from early development through commercialization.
News & Signals (0)
No linked news activity found for this company.